Joyzyme Group Limited (HKG:8622)
Hong Kong
· Delayed Price · Currency is HKD 0.350
+0.005 (1.45%)
At close: Mar 10, 2026
Joyzyme Group Company Description
Joyzyme Group Limited, an investment holding company, engages in the research, production, and sale of male fertility in-vitro diagnostic (IVD) reagents in the People's Republic of China.
The company provides biological reagents, including male fertility IVD reagents, parasite antibody detection reagents, and Epstein-Barr virus antibody detection reagent; and auxiliary reproductive supplies and equipment.
The company sells its products directly to hospitals and medical institutions, as well as to distributors.
The company was formerly known as Huakang Biomedical Holdings Company Limited and changed its name to Joyzyme Group Limited in January 2026.
Joyzyme Group Limited was founded in 1992 and is based in Tsim Sha Tsui, Hong Kong.
Joyzyme Group Limited
| Country | Cayman Islands |
| Founded | 1992 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 98 |
| CEO | Chunguang Zhang |
Contact Details
Address: Chinachem Golden Plaza Tsim Sha Tsui Hong Kong | |
| Website | joyzymebiotech.com |
Stock Details
| Ticker Symbol | 8622 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG4644W1069 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Chunguang Zhang | Chief Executive Officer and Executive Director |
| Lai Yin Poon CPA (Aust.), CPA (HKICPA) | Chief Financial Officer, Compliance Officer and Executive Director |
| Yujing Zhang | Co-Chairman |
| Dr. Xunyong Zhou | Co-Chairman |
| Lai Ki Chau | Financial Controller and Company Secretary |